Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
Holding APNHY?
Track your performance easily

Aspen Pharmacare (APNHY) Stock Price & Analysis

18 Followers

APNHY Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%<0.01%99.99%
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

APNHY FAQ

What was Aspen Pharmacare’s price range in the past 12 months?
Aspen Pharmacare lowest stock price was $9.01 and its highest was $13.85 in the past 12 months.
    What is Aspen Pharmacare’s market cap?
    Currently, no data Available
    When is Aspen Pharmacare’s upcoming earnings report date?
    Aspen Pharmacare’s upcoming earnings report date is Mar 06, 2025 which is in 113 days.
      How were Aspen Pharmacare’s earnings last quarter?
      Aspen Pharmacare released its earnings results on Oct 02, 2024. The company reported $0.568 earnings per share for the quarter, the consensus estimate of $0.568 by $0.
        Is Aspen Pharmacare overvalued?
        According to Wall Street analysts Aspen Pharmacare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Aspen Pharmacare pay dividends?
          Aspen Pharmacare pays a Annually dividend of $0.12 which represents an annual dividend yield of 1.23%. See more information on Aspen Pharmacare dividends here
            What is Aspen Pharmacare’s EPS estimate?
            Aspen Pharmacare’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Aspen Pharmacare have?
            Aspen Pharmacare has 446,252,320 shares outstanding.
              What happened to Aspen Pharmacare’s price movement after its last earnings report?
              Aspen Pharmacare reported an EPS of $0.568 in its last earnings report, expectations of $0.568. Following the earnings report the stock price went up 0.267%.
                Which hedge fund is a major shareholder of Aspen Pharmacare?
                Currently, no hedge funds are holding shares in APNHY
                ---

                Aspen Pharmacare Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                9.20%
                12-Months-Change

                Fundamentals

                Return on Equity
                5.11%
                Trailing 12-Months
                Asset Growth
                7.21%
                Trailing 12-Months

                Company Description

                Aspen Pharmacare

                Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the following segments: Therapeutic Focused Brands, Other Pharmaceuticals, and Nutritionals. The Therapeutic Focused Brands segment includes Anaesthetics and Thrombosis portfolios. The Nutritionals segment manufactures and markets in sub-Saharan Africa, Australia and Latin America. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
                ---

                APNHY Company Deck

                ---

                APNHY Earnings Call

                Q4 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Teva Pharmaceutical
                Dr Reddy's Laboratories
                Perrigo Company
                GlaxoSmithKline
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis